Omega-3 (DHA) May Help Lower Steroid Needs During Lupus Kidney Disease Remission in Mice
This laboratory study used a mouse model of lupus nephritis (kidney inflammation caused by lupus) to see whether the omega-3 fatty acid DHA could help maintain remission after standard immune-suppressing treatment, and whether it could reduce the amount of steroid medication needed.
Mice with silica-triggered lupus nephritis were treated with cyclophosphamide (a chemotherapy drug used to induce remission), then given either a control diet, DHA, a moderate dose of prednisone (a corticosteroid), or a combination of DHA plus prednisone. Researchers tracked kidney protein loss, autoantibody levels, survival, and tissue damage in the kidney, spleen, lung, and brain.
Mice receiving DHA alone or prednisone alone had improved survival compared to controls, but the combination of DHA plus prednisone was most effective at sustaining remission and reducing signs of disease across multiple organs. DHA also raised omega-3 levels in body tissues.
What this means for you
This is early-stage animal research, not a human clinical trial, so it doesn’t establish that omega-3s treat or prevent lupus in people. However, it raises an interesting possibility that omega-3 fatty acids like DHA might one day be studied alongside standard lupus therapies to help lower steroid doses—something researchers hope could reduce long-term steroid side effects, pending confirmation in human studies.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolThis summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.